A NEW INTERNATIONAL JOURNAL, Advances in Cell & Gene Therapy, recently published its inaugural issue in May 2018. The new publication aims to provide a forum for authors to share their newest results, views, and visions in the field of cell and gene therapy. The journal will be published on a quarterly basis by Wiley. Co–Editors-in-Chief are Syed A. Abutalib, MD, and Rupert Handgretinger, MD. Deputy Editors include James Armitage, MD; H. Joachim Deeg, MD; Hans Jochem Kolb, MD; Joseph Schwartz, MD; and Beth H. Shaz, MD.
Syed A. Abutalib, MD
Rupert Handgretinger, MD
James Armitage, MD
H. Joachim Deeg, MD
Hans Jochem Kolb, MD
Joseph Schwartz, MD
Beth H. Shaz, MD
This international journal features original peer-reviewed articles covering basic and clinical research relating to advances in cell, gene, and immune therapies in addition to their use in the treatment of nonmalignant and neoplastic hematologic diseases as well as some nonhematologic diseases.
The topics covered in Advances in Cell & Gene Therapy include hematopoietic cell transplants and immune therapies for all patient types with a wide range of disorders, including cancer. All articles include a section or feature detailing the current and future clinical implications of the research. Among the extensive Reviews, Case Reports, Expert Commentaries, and Perspectives, Advances in Cell & Gene Therapy provides a forum for presenting original research articles and sharing innovative ideas. To learn more about this journal, visit https://onlinelibrary.wiley. com/journal/25738461. ■
